Sung Yoon Lim

Dr. Sung Yoon Lim

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
SPSunny Park
Sunny Park
SPSo Hyang Park
So Hyang Park
YKYe ju Kim
Ye ju Kim
GLGeon Ho Lee
Geon Ho Lee
hyung-sook Kimhyung-sook Kim
hyung-sook Kim
SCSoo An Choi
Soo An Choi
Malnutrition in critically ill patients is closely linked with clinical outcomes. During acute inflammatory states, nutrition cannot reverse the loss of body cell mass completely. Studies on nutritional screening and strategy considering metabolic changes have not yet been conducted. We aimed to identify nutrition strategies using the modified Nutrition Risk in the Critically ill (mNUTIRC) score. Nutrition support data, laboratory nutrition indicators, and prognosis indices were prospectively collected on the 2nd and 7th day after admission. It was to identify the effect of the changes on the metabolic status and critical target of nutrition intervention. To discriminate the high-risk group of malnutrition, receiver operating characteristic curves were plotted. Risk factors associated with 28 day-mortality were evaluated using multivariable Cox proportional hazards regression. A total of 490 and 266 patients were analyzed on the 2nd and 7th day, respectively. Only the mNUTRIC score showed significant differences in nutritional risk stratification. The use of vasopressors, hypoprotein supply (<1.0 g/kg/day), high mNUTRIC score, and hypoalbuminemia (<2.5 mg/dL) in the recovery phase were strongly associated with a 28-day mortality. The implementation of the mNUTRIC score and protein supply in the post-acute phase is critical to improve 28-day mortality in critically ill patients.

1 January 2021 in Korean Circulation Journal
Verified
Journal Article
Open access
PDF file
SLSung Yoon Lim
Sung Yoon Lim
Sejoong KimSejoong Kim
Sejoong Kim
Korean Circulation Journal 대한심장학회지 순환기 Lim SY, et al. Korean Circ J. 2021 May;51:e83. https://doi.org/10.4070/kcj.2021.0996

1 January 2023 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
HKHyung-Jun Kim
Hyung-Jun Kim
DODong Kyu Oh
Dong Kyu Oh
SLSung Yoon Lim
Sung Yoon Lim
YCYoung-Jae Cho
Young-Jae Cho
SPSunghoon Park
Sunghoon Park
YLYeon Joo Lee
Yeon Joo Lee
Kim HJ, et al. J Korean Med Sci. 2023 Mar;38(10):e75. https://doi.org/10.3346/jkms.2023.38.e75

28 December 2023 in BMJ Open Respiratory Research
Verified
Journal Article
Open access
PDF file
HLHaeun Lee
Haeun Lee
MSMyung Jin Song
Myung Jin Song
YCYoung-Jae Cho
Young-Jae Cho
DKDong Jung Kim
Dong Jung Kim
SHSang-Bum Hong
Sang-Bum Hong
SLSung Yoon Lim
Sung Yoon Lim
Background Existing models have performed poorly when predicting mortality for patients undergoing venovenous extracorporeal membrane oxygenation (VV-ECMO). This study aimed to develop and validate a machine learning (ML)-based prediction model to predict 90-day mortality in patients undergoing VV-ECMO. Methods This study included 368 patients with acute respiratory failure undergoing VV-ECMO from 16 tertiary hospitals across South Korea between 2012 and 2015. The primary outcome was the 90-day mortality after ECMO initiation. The inputs included all available features (n=51) and those from the electronic health record (EHR) systems without preprocessing (n=40). The discriminatory strengths of ML models were evaluated in both internal and external validation sets. The models were compared with conventional models, such as respiratory ECMO survival prediction (RESP) and predicting death for severe acute respiratory distress syndrome on VV-ECMO (PRESERVE). Results Extreme gradient boosting (XGB) (areas under the receiver operating characteristic curve, AUROC 0.82, 95% CI (0.73 to 0.89)) and light gradient boosting (AUROC 0.81 (95% CI 0.71 to 0.88)) models achieved the highest performance using EHR’s and all other available features. The developed models had higher AUROCs (95% CI 0.76 to 0.82) than those of RESP (AUROC 0.66 (95% CI 0.56 to 0.76)) and PRESERVE (AUROC 0.71 (95% CI 0.61 to 0.81)). Additionally, we achieved an AUROC (0.75) for 90-day mortality in external validation in the case of the XGB model, which was higher than that of RESP (0.70) and PRESERVE (0.67) in the same validation dataset. Conclusions ML prediction models outperformed previous mortality risk models. This model may be used to identify patients who are unlikely to benefit from VV-ECMO therapy during patient selection.

22 August 2022 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
HWHyeonseong Woo
Hyeonseong Woo
SLSanghee Lee
Sanghee Lee
HLHyun Sung Lee
Hyun Sung Lee
HCHyun Jun Chae
Hyun Jun Chae
JJJongtak Jung
Jongtak Jung
JBJaewon Beom
Jaewon Beom
Woo H, et al. J Korean Med Sci. 2022 Aug;37(34):e262. https://doi.org/10.3346/jkms.2022.37.e262

30 September 2018 in Critical Care
Verified
Journal Article
Open access
PDF file
SLSung Yoon Lim
Sung Yoon Lim
WKWon Gun Kwack
Won Gun Kwack
Youlim KimYoulim Kim
Youlim Kim
YLYeon Joo Lee
Yeon Joo Lee
JPJong Sun Park
Jong Sun Park
YCYoung-Jae Cho
Young-Jae Cho
Percutaneous tracheostomy (PT) is a common procedure in critical care medicine. No definite clinical practice guidelines recommended on the choice of the direction of skin incision, vertical or transverse for tracheostomy in critically ill patients. The objective of this retrospective study was to compare the outcomes associated with vertical and transverse skin incisions in patients undergoing PT. Patients who underwent PT between March 2011 and December 2015 in the intensive care unit (ICU) of a tertiary hospital were retrospectively included. PTs were performed by pulmonary intensivists at the ICU bedside using the single tapered dilator technique assisted by flexible bronchoscopy. The primary outcome was the incidence of tracheostomy site ulcers at 7 days after PT. Of the 458 patients who underwent PT, a vertical incision was made in 27.1% and a transverse incision was made in 72.9%. There were no tracheostomy-related mortalities, and no significant difference in the incidence of immediate postoperative complications, including bleeding, tracheal ring fracture, and subcutaneous emphysema. Thirty-five patients (7.6%) developed complications within 7 days after PT, in which tracheostomy-related pressure ulcers were the most frequent. Compared with vertical incisions, transverse incisions were associated with significantly lower incidence of complications (14.1% vs. 5.4%, P = 0.001). This retrospective study showed that transverse skin incisions in PTs for critically ill patients, resulted in a significant decrease in overall complications, particularly ulcers in the tracheostomy site.